CIAM
CTKB icon

Caitong International Asset Management’s Cytek Biosciences CTKB Stock Holding History

Caitong International Asset Management’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Sell
3,322
-17,472
-84% -$74.6K ﹤0.01% 1058
2026
Q1 		$90.9K Buy
20,794
+15,650
+304% +$73.9K 0.02% 609
2025
Q4 		$26K Buy
5,144
+2,388
+87% +$11.1K 0.01% 929
2025
Q3 		$9.56K Buy
+2,756
New +$10.3K 0.01% 1030
2025
Q2 		– Sell
-319
Closed -$1.28K – 2089
2025
Q1 		$1.28K Buy
+319
New +$1.65K ﹤0.01% 1502

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Caitong International Asset Management's CTKB Position: Q2 2026 in Review

Caitong International Asset Management reduced its Cytek Biosciences (CTKB) stake by 84% in Q2 2026, selling an estimated $74.6K and leaving 3,322 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1058.

Caitong International Asset Management first reported a position in CTKB in Q1 2025 and has held it in 5 quarters since. The position peaked at $90.9K in Q1 2026. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Caitong International Asset Management held 3,322 shares of Cytek Biosciences worth $14.7K as of Q2 2026.
  • Caitong International Asset Management sold 17,472 Cytek Biosciences shares in Q2 2026, an estimated $74.6K.
  • Cytek Biosciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1058 holding.
  • Caitong International Asset Management first reported a position in Cytek Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Cytek Biosciences position peaked at $90.9K in Q1 2026.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.